HEALTH● LOWSep 3 · Sep 3, 2026, 2:52 PM
Pfizer, Medicus ink licensing deal worth up to $1B for antibody drug conjugate
Seeking Alpha Tech · global
Pfizer and Medicus have signed a licensing agreement valued up to $1 billion for an antibody drug conjugate.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH21m agoEurope doesn't 'care enough' about Ebola outbreak in DR Congo, says Mary RobinsonEuroNews [en]HEALTH1h agoKBN Hospital hosts workshop on hysterectomy and advanced laparoscopy in KalaburagiThe HinduHEALTH2h agoDangerous spices: How melted nylon additive keeps plantain chips crunchyVanguard NigeriaHEALTH2h agoMonitoring Of 62 Ebola Contacts To End By November 13 — NCDCChannels TV